Metraipolis › archive › dc_41e2affa87dd

Ivonescimab monotherapy in an elderly patient with EGFR-TKI-resistant advanced lung adenocarcinoma and pericardial effusion: a case report and literature review — Europe PMC PMID:42220530

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42220530
DOI
10.3389/fimmu.2026.1728444
License (as archived)
solo-consultazione
Archived
2026-11-02T11:11:56.938Z
SHA-256 of the archived text
ab63d70298ac862b64d847c0251fc84a4b1477896a3ff644ec1248a32039e151
Stable URL of this page
https://metraipolis.com/documento/dc_41e2affa87dd

How to cite

Ivonescimab monotherapy in an elderly patient with EGFR-TKI-resistant advanced lung adenocarcinoma and pericardial effusion: a case report and literature review — Europe PMC PMID:42220530 — Europe PMC (en), https://europepmc.org/article/MED/42220530 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_41e2affa87dd (Metraipolis archive dc_41e2affa87dd, sha256 ab63d70298ac862b64d847c0251fc84a4b1477896a3ff644ec1248a32039e151)
BibTeX
@misc{dc41e2affa87dd,
  title = {Ivonescimab monotherapy in an elderly patient with EGFR-TKI-resistant advanced lung adenocarcinoma and pericardial effusion: a case report and literature review — Europe PMC PMID:42220530},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42220530},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_41e2affa87dd; sha256 ab63d70298ac862b64d847c0251fc84a4b1477896a3ff644ec1248a32039e151},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42220530. Agents can read the archived copy with the MCP tool read_document.